| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
VOLUNTARY SUSPENSION UPDATE
|
10 Sep 2024 10:20AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$12 |
Appendix 3 Y - Damian Banks
|
10 Sep 2024 10:16AM |
$0.470 |
$0.225 |
fallen by
52.13%
|
|
| ABx Group Limited (ABX) ORDINARY FULLY PAID |
Materials |
$10 |
R&D Tax Rebate Received for Rare Earths Activities
|
10 Sep 2024 10:15AM |
$0.043 |
$0.041 |
fallen by
4.65%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$102,992 |
Application for quotation of securities - CSL
|
10 Sep 2024 10:12AM |
$302.630 |
$212.700 |
fallen by
29.72%
|
|
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$42 |
Replacement Prospectus
|
10 Sep 2024 10:11AM |
$0.005 |
$0.110 |
risen by
2,100%
|
|
GTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Gratifii Limited (Gratifii) is conducting an accelerated non-renounceable pro-rata entitlement offer.
- The offer is made to eligible shareholders of 1 new share for every 1.28 shares held at $0.004 per new share.
- The company aims to raise approximately $5.5 million from this offer.
- Funds from the offer will be used mainly for repaying convertible notes, working capital, costs of the placement, and acquisitions of Club Connect and Rapport.
- The replacement prospectus updates details from the original prospectus dated 9 September 2024.
- The entitlement offer includes both institutional and retail components.
- MST Financial is managing the placement and offers and partially underwriting the retail offer.
- The prospectus highlights significant risks, including acquisition risks, shareholder approval risks, underwriting risks, and failure to retain customers.
- An Extraordinary General Meeting (EGM) is to be held to obtain shareholder approval for issuing shares related to acquisitions and placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kali Metals Limited (KM1) ORDINARY FULLY PAID |
Materials |
$15 |
Soil Sampling Results at Jingellic Project
|
10 Sep 2024 10:10AM |
$0.145 |
$0.165 |
risen by
13.79%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$172 |
Change of Director's Interest Notice - RSZ
|
10 Sep 2024 10:09AM |
$1.350 |
$1.280 |
fallen by
5.19%
|
|
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$22 |
Company update presentation
|
10 Sep 2024 10:07AM |
$0.023 |
$0.029 |
risen by
26.09%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$172 |
Change of Director's Interest Notice - IK
|
10 Sep 2024 10:07AM |
$1.350 |
$1.280 |
fallen by
5.19%
|
|
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$106 |
ALA presents at Cell and Gene Therapy World Asia Conference
|
10 Sep 2024 9:58AM |
$0.140 |
$0.089 |
fallen by
36.43%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$118 |
Update - Notification of buy-back - TOP
|
10 Sep 2024 9:58AM |
$0.635 |
$0.675 |
risen by
6.30%
|
|
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$26 |
FIREBIRD RECEIVES KEY ENVIRONMENTAL PERMIT
|
10 Sep 2024 9:56AM |
$0.105 |
$0.180 |
risen by
71.43%
|
|
FRB - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebird Metals Limited has received the Environmental Permit for its battery grade manganese sulphate plant in Jinshi, Hunan Province, China.
- This Environmental Permit is the second of three critical permits required, with the Energy Permit expected soon.
- Firebird's subsidiary, Hunan Firebird Battery Technologies, signed MOUs with several Chinese cement and brick manufacturers to utilize leach residue in their production processes.
- Completion of the plant is projected to take 12-15 months, with operations expected to commence in late 2025.
- Firebird has received significant support from the Jinshi Government, aiding in the timely receipt of permits.
- The Environmental Permit demonstrates Firebird's commitment to a zero-waste process and circular industry operations.
- Firebird is focusing on becoming a near-term producer of high-purity manganese sulphate for the EV battery sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$154 |
Cleansing Notice
|
10 Sep 2024 9:56AM |
$0.115 |
$0.160 |
risen by
39.13%
|
|
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$154 |
Proposed issue of securities - GLN
|
10 Sep 2024 9:56AM |
$0.115 |
$0.160 |
risen by
39.13%
|
|
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$154 |
Proposed issue of securities - GLN
|
10 Sep 2024 9:56AM |
$0.115 |
$0.160 |
risen by
39.13%
|
|
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$154 |
A$25m Capital Raise to Support Full Funding of HMW Phase 1
|
10 Sep 2024 9:56AM |
$0.115 |
$0.160 |
risen by
39.13%
|
|
GLN - Price-sensitive ASX Announcement
Full Release
Key Points
- Galan to raise up to A$25 million through a placement and entitlement offer
- Placement to institutional, sophisticated, professional investors at A$0.105 per share
- Entitlement offer of 1 for 4 at the same price to raise up to A$13.3 million
- Chemphys to subscribe for A$4.5 million under the placement, subject to definitive agreements
- Funds will support HMW Phase 1 development, corporate overheads, and working capital
- Galan Lithium owns HMW and Candelas lithium brine projects in Argentina
- HMW has a significant potential with an updated resource estimate of 7.9Mt of LCE at 883mg/l Li
- The entitlement offer record date is 13 September 2024 and closes on 3 October 2024
- The placement is not underwritten
- Chemphys participation subject to a sunset date of 31 December 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$7 |
Reinstatement to Official Quotation
|
10 Sep 2024 9:54AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
LNU - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of trading in Linius Technologies Limited (LNU) securities lifted.
- Reinstatement follows LNU's announcement regarding capital raising.
- Trading resumed from 10 September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$7 |
Investor presentation
|
10 Sep 2024 9:54AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$7 |
Proposed issue of securities - LNU
|
10 Sep 2024 9:53AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$7 |
Proposed issue of securities - LNU
|
10 Sep 2024 9:53AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
| Linius Technologies Limited (LNU) ORDINARY FULLY PAID |
Information Technology |
$7 |
Linius funded with up to $3 million capital raising
|
10 Sep 2024 9:53AM |
$0.002 |
$0.001 |
fallen by
50%
|
|
LNU - Price-sensitive ASX Announcement
Full Release
Key Points
- Linius Technologies Limited to raise up to $3 million in capital
- Funding includes $1.5 million equity placement and $1.5 million standby equity facility with Eli Capital
- Binding commitments under a convertible note facility contribute to the capital
- Targeting cashflow break-even in early FY26
- Cost reductions of nearly $1 million annually implemented
- New product Captivate released
- Partnerships with Prime Focus, Magnifi, and Avid
- Significant penetration in the global sports broadcasting market
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$53 |
Update - Notification of buy-back - TEK
|
10 Sep 2024 9:52AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$267 |
First patient enters into Open Label Extension study
|
10 Sep 2024 9:51AM |
$0.405 |
$0.445 |
risen by
9.88%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- First patient enters DMX-200 Open Label Extension (OLE) study after successfully completing the ACTION3 Phase 3 clinical trial
- The OLE study allows patients who have successfully completed the ACTION3 Phase 3 clinical trial to optionally start or continue a 2-year treatment of DMX-200 in an open label setting
- All patients in the OLE study will receive DMX-200, regardless of their treatment during the randomised and blinded phase of the ACTION3 Phase 3 clinical trial
- The OLE study will collect additional long-term data on DMX-200 to support future regulatory filings
- 116 patients have currently been randomised/dosed in the ACTION3 Phase 3 clinical trial
- The OLE study evaluates the longer-term safety and efficacy of DMX-200 treatment in patients with focal segmental glomerulosclerosis (FSGS)
- The study allows participants from the ACTION3 trial to continue receiving the drug until potential market approval is obtained
- A properly designed OLE study provides rigorous information on long-term safety and tolerability of new drugs and helps in the drug licensing process
- Data collected during the OLE study includes changes in urine protein to creatinine ratio (UPCR) and estimated glomerular filtration rate (eGFR)
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arafura Rare Earths Ltd (ARU) ORDINARY FULLY PAID |
Materials |
$510 |
Initial Director's Interest Notice
|
10 Sep 2024 9:51AM |
$0.150 |
$0.180 |
risen by
20%
|
|
| Tempest Minerals Limited (TEM) ORDINARY FULLY PAID |
Materials |
$6 |
Yalgoo Update - Commencement Of Drilling At Remorse
|
10 Sep 2024 9:49AM |
$0.011 |
$0.005 |
fallen by
54.55%
|
|
TEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of 5,000m of reverse circulation drilling at the Remorse Target
- Drilling operations initiated at the Remorse Copper Target within the Yalgoo Project
- Previous geochemical and geophysical surveys indicated significant potential
- Drilling program designed to test the central area of the Remorse Target
- Yalgoo Project spans over 1,000 square kilometers
- Expansion of current drilling program due to long-term exploration efforts
- Ongoing analysis of drill results with potential for further drilling
- Continued exploration activities within the portfolio
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
